Hemostemix Inc. (CVE:HEM – Get Free Report) shares crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of C$0.13 and traded as low as C$0.13. Hemostemix shares last traded at C$0.13, with a volume of 1,000 shares.
Hemostemix Trading Up 4.2 %
The firm has a fifty day moving average price of C$0.13 and a 200 day moving average price of C$0.14. The firm has a market cap of C$10.56 million, a PE ratio of -2.08 and a beta of 0.63.
About Hemostemix
Hemostemix Inc, a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patient's own blood, which is a non-invasive source of therapeutic cells. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia in Canada and the United States.
See Also
- Five stocks we like better than Hemostemix
- What Investors Need to Know to Beat the Market
- These Quality Dividend Kings Grow their Dividends the Fastest
- What Does a Stock Split Mean?
- 3 Growth Stocks to Buy in September
- How to Invest in Solar Energy
- 3 Underappreciated Stocks with Nowhere to Go But Up
Receive News & Ratings for Hemostemix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hemostemix and related companies with MarketBeat.com's FREE daily email newsletter.
